Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07187700Not Yet Recruiting

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study

Role: collaborator

NCT06809959Not ApplicableRecruiting

Bifocal Transcranial Alternating Current Stimulation Targeting the Frontoparietal Network in Stroke Patients

Role: collaborator

NCT05576129Not ApplicableCompleted

Transcranial Alternating Current Stimulation (tACS) to Improve Motor Skill Acquisition in Stroke Patients

Role: collaborator

NCT03564236Not ApplicableRecruiting

Nasal High-Flow in COPD

Role: collaborator

NCT06206369Recruiting

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

Role: collaborator

NCT01151631Phase 3Completed

Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache

Role: collaborator

NCT01667705Completed

To Examine the Effect of a View of Nature on Patient's Stress and Anxiety

Role: collaborator

NCT00217243Completed

Evoked Fields After Median and Ulnar Stimulation

Role: collaborator

All 8 trials loaded